Tom Nolan reviews this week’s research “Small individual gain, larger population gain” sounds like the theme for a preventive medicine conference. It’s actually the headline of an editorial about a ...

High blood pressure stands among the leading causes of stroke, yet many people fail to recognize the critical importance of ...

Few drugs have captured public attention like Ozempic ... because when you do eat … it sets off an entire cascade” of mostly peptide hormones as well as neurologic signals (such as signals ...

Many of the new drugs coming out are combinations, so they are mimicking many different hormones, and that, if you think about it, is going to be much more physiologic, because when you do eat … it ...

The absolute number of new biologic drug approvals in any given year is ... which normally dampens the complement cascade. CSL Behring, of King of Prussia, Pennsylvania, gained CBER approval ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

Citation: Anti-clotting drug significantly reduces bleeding events in patients with atrial fibrillation, clinical trial shows (2025, January 23) retrieved 11 February 2025 from https ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study.

Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the ...